Concepedia

Publication | Open Access

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data

DOIFull Paper Access

37

Citations

9

References

2018

Year

Hermann Eichler, Pantep Angchaisuksiri, Kaan Kavaklı, Paul Knoebl, Jerzy Windyga, Víctor Jiménez‐Yuste, Philip Harder Delff, Pratima Chowdary
Haemophilia

Abstract

Concizumab phase 2 trials will target an exposure ≥100 ng/mL, with a once-daily regimen.

References

YearCitations

Page 1